Get the latest delivered to your inbox
Privacy Policy

Now Reading

Historic CEO Commitment to Help Stop AIDS

Historic CEO Commitment to Help Stop AIDS

Published 12-01-08

Submitted by GBCHealth

New York, NY. - December 1, 2008 - CEOs from companies including Chevron, Dell, ExxonMobil, Heineken, Coca-Cola, Gap and Nike today made an unprecedented pledge to end workplace HIV discrimination and stigma in their companies.

In all, more than 100 members of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria made the historic commitment - reaching approximately five million employees around the world.

Eradicating stigma and discrimination is critical to defeating HIV/AIDS, which has claimed more than 25 million lives.

"Stigma and discrimination kill," said Coalition President and CEO Richard Holbrooke. "They keep people from getting tested, and from getting care and support if they need it. Ending stigma is one of the most effective things anyone can do to stop AIDS.

"By making its powerful voice clear, business is providing much needed leadership which will, in turn, influence the behavior and actions of other businesses, governments and individuals," Holbrooke continued. "Collective, coordinated action on AIDS, and business action, is critical. It's impossible to win the fight without it."

The signatories' action delivered a clear message that their companies are taking concrete action to end HIV/AIDS. Workplace policies increase the rate of HIV testing and treatment, and corporate attitudes often have significant impact on communities, governments and business partners.

To learn more about the Coalition and its drive to mobilize the power of business to achieve bigger results in the fight against AIDS, TB and Malaria visit:

http://www.gbcimpact.org/live/feature/strategy.php


The full list of CEO signatories to the pledge follows:


Miles D. White, Abbott

Aigboje Aig-Imoukhuede, Access Bank Plc

Gilles Pelisson, Accor

Cynthia Carroll, Anglo American plc

Margery Kraus, APCO Worldwide

Anne Lauvergeon, AREVA Group

Kabelo Antony Ebineng, Associated Fund Administrators Botswana (Pty) Ltd

David R Brennan, AstraZeneca

Rahul Bajaj, Bajaj Auto

Peter Munk, Barrick Gold Corporation

Werner Wenning, Bayer AG

Edward J. Ludwig, BD (Becton, Dickinson and Company)

Vimal B.Shah, Bidco Oil Refineries Limited

Stephane Bancel, bioMerieux

Birger Sorensen, Bionor Immuno

Debra L. Lee, Black Entertainment Television (BET)

William Downe, BMO Financial Group

Dr. Alessandro Banchi, Boehringer Ingelheim

Shumeet Banerji, Booz & Company

Tony Hayward, BP

Michael T. Dan, The Brink's Company

James Cornelius, Bristol-Myers Squibb

Michael Predeaux, British American Tobacco

Mark Penn, Burson-Marsteller

Dave O'Reilly, Chevron Corporation

Gerald T. McCaughey, CIBC

Vikram Pandit, Citigroup

Muhtar Kent, The Coca-Cola Company

Samer Khoury, Consolidated Contractors International Company S.A.L. (CCC)

Dr. Dieter Zetsche, Daimler AG

N. F. Oppenheimer, De Beers

Blackie Marole, Debswana

Michael Dell, Dell

James H. Quigley, Deloitte Touche Tohmatsu

Gerald Mahinda, East African Breweries Limited

Gennady Gazin, EastOne LLC

Richard Edelman, Edelman

Christian Kemp Griffin, EDUN

John Lechleiter, Eli Lilly and Company

Phirwa Jacob Maroga, Eskom

Martin Vial, Europ Assistance Holding

Rex Tillerson, Exxon Mobil Corporation

Jacqueline Mugo, Federation of Kenyan Employers

Glen K. Murphy, Gap Inc.

Jonathan D. Klein, Getty Images

Alexander Saint-Amand, Gerson Lehrman Group

Andrew P. Witty, GlaxoSmithKline

Dong Soo Hur, GS Caltex Corporation

P. Igathe, Haco Industries Ltd

William A. Haseltine, Haseltine Global Health

Jean-Francois van Boxmeer, Heineken N.V.

Richard Plepler, Home Box Office (HBO)

Victor Y. Yuan, Horizon Research Group

Frank Ireri, Housing Finance Company of Kenya Limited

Anthony L. Howard, Independent Newspapers (Pty) Ltd

Heather Reisman, Indigo Books & Music Inc.

Corrado Passera, Intesa Sanpaolo

Jena Gardner, JG Black Book of Travel

William C. Weldon, Johnson & Johnson

Gerard J. Inzerillo, Kerzner International

Derek J. Oatway, KK Security (Kenya Kazi Services Ltd)

Bruno Lafont, Lafarge

John Anderson, Levi Strauss & Co.

Beatrice Dautresme, L'Oréal

John Demsey, MAC Cosmetics / MAC AIDS Fund

Ian E.L. Davis, McKinsey & Company

Richard Clark, Merck & Co., Inc.

L W Nkuhlu, Metropolitan

Dennis Pinto, Micato Safaris

Samir Modi, Modicare

William H. Roedy, MTV Networks

Robert J. Coury, Mylan Inc.

Gary Ginsberg, News Corporation

Mark Parker, Nike, Inc.

David Stern, National Basketball Association (NBA)

Daniel Vasella, M.D., Novartis

Duncan L. Niederauer, NYSE Euronext, Inc.

Marcia Silverman, Ogilvy Public Relations Worldwide

Douglas A Michels, OraSure Technologies

Jeff Kindler, Pfizer Inc.

Christie Hefner, Playboy Enterprises Inc.

Naresh S. Mehta, Power Technics

Neil Mehta, Premier Medical Corporation

Maurice Levy, Publicis

Malvinder Mohan Singh, Ranbaxy Laboratories Limited

Thomas H. Glocer, Reuters

Tom Albanese, Rio Tinto

Simon Cooper, The Ritz-Carlton Hotel Company

Gordon M. Nixon, Royal Bank of Canada

Dr. Ganesh P. Rane, RRR Industries

Matthew J. Wright, Russell Reynolds Associates

Graham Mackay, SABMiller plc

Fred Hassan, Schering-Plough Corporation

Rick Waugh, Scotiabank Group

Ai Lianghua, Shanghai Desano Pharmaceuticals Holding Company Ltd

Pete Ruegger, Simpson, Thacher & Bartlett

Christian Jourquin, Solvay

Gary Watts, SSL International plc

Clive Tasker, Standard Bank

Peter Sands, Standard Chartered Bank

Hiromasa Yonekura, Sumitomo Chemical

Scott Mullin, TD Bank Financial Group

Carol Johnston, Times Media Group

Christophe de Margerie, Total

John Noel, Travel Guard

Marie-Christine de Saragosse, TV5

Patrick Cescau, Unilever

Henri Proglio, Veolia Environment

Mikkel Vestergaard Frandsen, Vestergaard Frandsen

Phillippe Dauman, Viacom International

Sir Richard Branson, Virgin

Martin Winterkorn, Volkswagen

S. Shiryaev, Vostok-Service

Lev Partskhaladze, XXI Century Investments

Mick Davis, Xstrata

Dr. Subhi Quraishi, ZMQ Software Systems



Global Business Coalition on HIV/AIDS, TB and Malaria

The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria is a coalition of more than 220 companies united to keep the fight against these epidemics a global priority. The Coalition provides tailored support so that companies can take an active role in defeating the pandemics. The Coalition also organizes collective actions among companies and links the public and private sectors in ways that pool talents and resources. The official focal point of the private sector delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Coalition maintains offices in New York, Paris, Johannesburg, Beijing, Nairobi and Moscow. For more information visit: http://www.gbcimpact.org

GBCHealth Logo

GBCHealth

GBCHealth

GBCHealth is the preeminent organization focused on business engagement in support of meeting global goals for health. Its vision is health equity and a global business community that contributes its assets, skills, influence and reach to create a healthier world for employees, their families, and communities. GBCHealth works with companies worldwide and with the United Nations, governments, academia, civil society & others. In September 2022, GBCHealth launched future united, a global initiative harnessing the power of the private sector to fight for - and achieve - health equity, tackle the impact of climate change on health, and address antimicrobial resistance and future pandemics.

More from GBCHealth

Join today and get the latest delivered to your inbox